Process of Experimentation Test

The Process of Experimentation test is a legal requirement that research activities must involve a systematic evaluation of alternatives through testing, modeling, or trial and error to resolve technical uncertainties. In the context of the New Jersey R&D tax credit, this test ensures that only rigorous, science-based innovation qualifies for the 10% corporate tax offset.

The New Jersey Research and Development (R&D) tax credit, codified under N.J.S.A. 54:10A-5.24, represents a sophisticated fiscal instrument designed to foster a high-tech ecosystem within the state. The “Process of Experimentation” (PoE) component of this credit is perhaps the most critical and scrutinized element of the qualification process, acting as the primary filter between routine business activity and genuine scientific advancement. Under the modern New Jersey tax code, this test is inextricably linked to the federal standards established in Section 41 of the Internal Revenue Code (IRC), following a landmark “recoupling” that occurred in 2018. This alignment means that for a New Jersey business to successfully claim the credit, it must demonstrate that substantially all of its research activities involve a systematic process to evaluate alternatives—such as modeling, simulation, or systematic trial and error—to achieve a result where the capability, method, or design was uncertain at the project’s inception. This report provides an exhaustive analysis of the PoE test, its administrative implementation by the New Jersey Division of Taxation, and its intersection with judicial precedents and state-specific incentives.

Statutory Basis and Legislative Context

The New Jersey Research and Development Tax Credit was originally enacted in 1993 to reward corporations for conducting qualified research activities within the state’s borders. For decades, the state maintained a “frozen” conformity to the federal tax code as it existed in 1992, which created significant administrative friction for taxpayers who had to navigate divergent rules for state and federal returns. This changed significantly with the passage of P.L. 2018, c. 48, which updated the New Jersey Corporation Business Tax (CBT) Act to align with current federal IRC Section 41 provisions for privilege periods beginning on or after January 1, 2018.

Under N.J.S.A. 54:10A-5.24, a taxpayer is allowed a credit against the tax imposed by the CBT Act in an amount equal to 10% of the excess of the qualified research expenses for the privilege period over the base amount, plus 10% of basic research payments. The definition of “qualified research” is explicitly tied to the federal definition, which incorporates the “Four-Part Test”. The PoE test is the third and arguably most demanding prong of this test, requiring that the taxpayer’s work constitute a process of experimentation for a qualified purpose.

The legislative intent behind this alignment was to simplify compliance while ensuring that the credit supports industries central to New Jersey’s “innovation economy,” such as pharmaceuticals, biotechnology, advanced materials, and computer science. However, this conformity also means that New Jersey taxpayers are subject to the same rigorous documentation standards and audit scrutiny as those claiming the federal credit. The Division of Taxation emphasizes that only expenditures for research conducted within New Jersey qualify, requiring businesses to maintain precise records of where their experimentation takes place.

The Four-Part Test: A Structural Analysis

To understand the Process of Experimentation test, one must view it within the broader architecture of the Four-Part Test. New Jersey follows the federal framework where a business component—defined as any product, process, software, technique, formula, or invention to be held for sale, lease, or license, or used in a trade or business—must satisfy four cumulative criteria.

Component of the Test	Requirement Summary	Legal Authority
Permitted Purpose	The activity must relate to a new or improved function, performance, reliability, or quality of a business component.	IRC § 41(d)(1)(B)(ii)
Technological in Nature	The research must fundamentally rely on principles of physical or biological sciences, engineering, or computer science.	IRC § 41(d)(1)(B)(i)
Elimination of Uncertainty	The activity must be intended to discover information that eliminates technical uncertainty regarding capability, method, or design.	IRC § 41(d)(1)(A)
Process of Experimentation	Substantially all (80% or more) of the activities must constitute a process of experimentation involving the evaluation of alternatives.	IRC § 41(d)(1)(C)

The Process of Experimentation test acts as the operational bridge between the “uncertainty” and the “technological” prongs. While the uncertainty prong identifies the problem, and the technological prong identifies the tools used to solve it, the PoE prong describes the actual conduct of the research. It requires more than just a successful outcome; it requires a documented method of discovery.

Defining the Process of Experimentation (PoE) Test

The core of the PoE test is the systematic evaluation of one or more alternatives. This evaluation is intended to resolve the technical uncertainties identified at the outset of the project. Under Treasury Regulation § 1.41-4(a)(5), a process of experimentation is defined as a process involving the evaluation of more than one alternative to achieve a result where the capability or the method of achieving that result, or the appropriate design of that result, is uncertain as of the beginning of the taxpayer’s research activities.

The Division of Taxation and the federal courts have clarified that this process generally follows a “scientific method” approach. This includes:

1. Hypothesis Formation: Identifying a potential solution or design path based on scientific principles.
2. Testing and Observation: Evaluating the hypothesis through modeling, simulation, or physical trial and error.
3. Refinement: Analyzing the results of the tests and using that data to refine, discard, or confirm the original hypothesis.

A critical nuance in the New Jersey context is the “substantially all” requirement. This rule, often called the “80% Rule,” mandates that 80% or more of the research activities, measured by cost or time, must constitute a process of experimentation. If a project fails to meet this threshold at the aggregate level, the taxpayer must apply the “shrinking-back” rule to identify a smaller sub-component—such as a specific software module or a particular chemical additive—that does meet the test.

New Jersey Division of Taxation Guidance and Administrative Requirements

The New Jersey Division of Taxation provides comprehensive guidance through Technical Bulletins, specifically TB-114 (Revised November 2025) and N.J.A.C. 18:7-3.23. These documents outline the state’s expectations for compliance and the intersection of the PoE test with New Jersey’s specific tax environment.

Technical Bulletin TB-114: The Compliance Roadmap

TB-114 serves as the primary administrative authority for the R&D credit. It reiterates that for tax years beginning on and after January 1, 2018, taxpayers must use the same method for New Jersey that they used on their federal returns for calculating the credit. This means if a taxpayer elects the Alternative Simplified Credit (ASC) method federally, they must use it for New Jersey purposes on Form 306.

One of the most significant aspects of TB-114 is the emphasis on “substantiation requirements”. The Division explicitly states that substantiation is necessary to ensure research is performed in New Jersey and that expenditures are not being double-counted toward other credits. For the PoE test, this means the taxpayer must be able to produce project records that clearly link NJ-based wages and supplies to specific experimental iterations.

Form 306: Reporting the Process of Experimentation

The mechanism for claiming the credit is Form 306, “Research and Development Tax Credit”. This form requires a breakdown of qualified research expenses, including wages for qualified services, the cost of supplies, and contract research expenses.

Expenditure Type	Qualification in Context of PoE	Statutory Reference
Wages	Salaries for employees directly engaging in, supervising, or supporting the experimentation process in NJ.	N.J.S.A. 54:10A-5.24(a); N.J.A.C. 18:7-3.23
Supplies	Tangible property (excluding capital equipment) consumed or used in the NJ experimentation process, such as lab chemicals or prototype materials.	N.J.A.C. 18:7-3.23(c)
Contract Research	65% of payments to third parties for experimentation services conducted in New Jersey.	N.J.A.C. 18:7-3.23
Computer Rentals	Leasing costs for computers used directly in conducting the experimentation (often relevant for software simulation).	N.J.A.C. 18:7-3.23

The instructions for Form 306 specifically exclude research conducted after the beginning of commercial production, research adapting existing products to specific customer needs, and research in social sciences or humanities. These exclusions are designed to protect the integrity of the PoE test, ensuring that “experimentation” is not confused with routine business adaptation or market research.

The PoE Test in Practice: A Narrative Example

To illustrate the application of the Process of Experimentation test within a New Jersey business, consider a hypothetical medical device company based in New Brunswick developing a new type of biocompatible stent.

The company identifies a technical uncertainty: whether a specific gold-palladium alloy will provide sufficient structural integrity while remaining visible under standard MRI equipment without causing imaging artifacts. This uncertainty relates to the design and capability of the alloy. Because the solution is not readily available in existing metallurgical literature, the company must undergo a process of experimentation.

The engineering team begins a systematic trial-and-error process. In the first phase, they create five different alloy ratios. They use computer-aided design (CAD) software to simulate the stresses the stent will face in a coronary artery, representing the “modeling and simulation” aspect of PoE. They then build physical prototypes of each ratio in their Newark-based lab.

Each prototype is subjected to rigorous testing. Ratio A is too brittle; Ratio B interferes with the MRI signal. The team analyzes the failure data, refines their hypothesis regarding the specific percentage of palladium needed, and proceeds to a second round of testing with Ratios C and D. This iterative cycle—identifying a failure, analyzing the cause, and modifying the design—is exactly what the New Jersey Division of Taxation looks for to satisfy the PoE test.

The company documents this entire journey: the initial CAD files, the logs from the metallurgical tests, the reasons why Ratios A and B were discarded, and the final verification that Ratio D met all safety and visibility standards. Because these activities took place in New Jersey and were driven by scientific principles to resolve technical unknowns through iterative testing, they pass the PoE test and qualify for the 10% credit under N.J.S.A. 54:10A-5.24.

Judicial Precedents and Audit Scrutiny

The Process of Experimentation test is the most common point of failure in R&D audits. Both federal and state authorities have high documentation bars, and several recent tax court cases provide vital lessons for New Jersey businesses.

Phoenix Design Group, Inc. v. Commissioner (2024)

In Phoenix Design Group, Inc. v. Commissioner, the U.S. Tax Court (whose rulings inform New Jersey’s interpretation due to recoupling) disallowed R&D credits for an engineering firm because it could not demonstrate a systematic process of experimentation. The court found that the firm’s six-stage design process was linear and lacked the iterative, hypothesis-driven testing required by IRC § 41(d).

The court emphasized three primary failures that New Jersey companies must avoid:

1. Routine Design vs. Experimentation: Many of the activities were routine adaptations or code compliance checks, not aimed at resolving a genuine technical uncertainty.
2. Lack of Iterative Testing: The firm could not prove it evaluated alternatives or refined its designs based on experimental results.
3. Inadequate Records: The firm relied on testimony that was inconsistent with contemporaneous records, leading to a 20% accuracy-related penalty.

Siemer Milling Company v. Commissioner

Another influential case, Siemer Milling Company v. Commissioner, underscored the need for documentation that establishes the “scientific method”. The court held that the taxpayer failed the PoE test because it did not conduct trials to test a hypothesis, analyze the data, and refine the hypothesis. This case highlights that simply “trying something to see if it works” is not the same as a “systematic process of experimentation” in the eyes of the law.

Documentation and Substantiation Strategies

For New Jersey businesses, surviving an audit of the PoE test requires a transition from “retrospective narrative” to “contemporaneous documentation”. The Division of Taxation expects a clear trail that links time and expenses to specific research objectives.

Essential Records for PoE Compliance

A robust documentation package should include the following elements:

• Project Narrative: A contemporaneous document identifying the technical uncertainties at the project’s start and the scientific principles relied upon to solve them.
• Design and Prototype Records: Plans, CAD files, and photographs of prototypes at various stages of development.
• Test Logs and Results: Detailed records of the experiments conducted, including the variables changed, the hypotheses being tested, and the data gathered from failures.
• Employee Activity Logs: Records showing the specific time spent by NJ-based employees on qualified experimentation versus routine production or maintenance.
• Alternative Evaluations: Board minutes, emails, or internal reports discussing the different design paths considered and the reasons for selecting or rejecting them.

The Division of Taxation may also review “nexus” documentation—records that prove the connection between a specific expense (like a scientist’s wage) and the qualifying experimentation activity.

New Jersey Specific Incentives and the PoE Test

New Jersey offers several programs that amplify the value of the R&D credit, but they all fundamentally rely on the taxpayer’s ability to pass the PoE test.

The NJEDA Technology Business Tax Certificate Transfer Program

Perhaps the most unique feature of the New Jersey tax landscape is the ability for unprofitable technology and biotechnology firms to sell their unused R&D credits for cash. Administered by the New Jersey Economic Development Authority (NJEDA) in cooperation with the Division of Taxation, this program allows companies to sell credits for at least 80% of their face value to other CBT taxpayers.

Program Detail	Requirement/Value
Annual Pool	$75 million (with set-asides for Innovation Zones)
Eligibility	Fewer than 225 U.S. employees; specific NJ employment thresholds
Maximum Benefit	$20 million lifetime cap per firm
Transfer Rate	Minimum 80% of the value of the tax benefit

The PoE test is critical here because the NJEDA requires a valid certification from the Division of Taxation that the credits were earned through qualified research. If an audit later determines that the activities did not constitute a “process of experimentation,” the credits could be recaptured, creating significant liability for the selling company.

Extended Carryforward for Priority Industries

New Jersey provides a standard seven-year carryforward for unused R&D credits. However, this is extended to 15 years for businesses conducting research in specific “priority” fields. This extension recognizes the long R&D cycles inherent in these sectors, where the experimentation process can span over a decade before a product reaches commercial viability.

Priority Industries for 15-Year Carryforward:

• Advanced Computing
• Advanced Materials
• Biotechnology
• Electronic Device Technology
• Environmental Technology
• Medical Device Technology

Calculating the New Jersey R&D Credit

Following the 2018 recoupling, New Jersey taxpayers must follow the same method—Regular or ASC—that they use on their federal returns.

The Regular Credit Method

The Regular Method is an “incremental” credit, rewarding companies for increasing their R&D spend relative to a historical base.

NJ Credit = 0.10 x (Current NJ QREs – Base Amount)

The “Base Amount” is calculated by multiplying the “Fixed-Base Percentage” (the ratio of historical R&D spend to gross receipts) by the average of the company’s New Jersey gross receipts for the prior four years. Importantly, New Jersey mandates that the base amount cannot be less than 50% of the current year’s QREs.

The Alternative Simplified Credit (ASC) Method

The ASC method is often preferred by startups or firms with fluctuating R&D budgets because it does not require historical gross receipts data.

ASC Credit = 0.10 x (Current NJ QREs – (Sum of NJ QREs for prior 3 years / 6))

This formula effectively provides a 10% credit on the portion of current R&D spending that exceeds 50% of the average of the prior three years. If a company has no R&D spend in any of the prior three years, the credit is typically 6% of the current year’s NJ QREs.

Economic Nexus and Apportionment

With the adoption of Market-Based Sourcing and single-factor sales apportionment for CBT purposes, New Jersey has expanded its “Economic Nexus” rules. For privilege periods ending on or after July 31, 2023, a corporation is deemed to have nexus with New Jersey if its receipts from NJ sources exceed $100,000 or if it has 200 or more separate transactions delivered to NJ customers.

This has significant implications for the R&D credit. Companies that previously did not have a physical presence in the state but now meet these economic thresholds may find themselves subject to NJ CBT—and therefore eligible to claim the R&D credit for any qualified research they do perform within the state. Conversely, for companies with research activities in multiple states, the Division requires precise apportionment. If the exact amount of NJ-based QREs cannot be determined, the taxpayer may use a three-factor allocation (property, payroll, and receipts) to estimate the in-state portion of their experimentation costs, subject to Division audit.

Interaction with Other State Provisions

The New Jersey R&D credit does not exist in a vacuum; it interacts with several other components of the CBT Act.

The CBT Surtax

New Jersey has historically applied a surtax on allocated taxable net income for businesses exceeding $1 million in income. The R&D credit is applied against the “entire net income component” of the tax before the surtax is calculated, though the exact priority of credits is determined by the Director of the Division of Taxation.

Section 174 Amortization

A major change in the federal tax landscape—and by extension, New Jersey’s—is the requirement under the Tax Cuts and Jobs Act (TCJA) to capitalize and amortize R&D expenses. For tax years beginning after December 31, 2021, domestic research expenses must be amortized over five years, and foreign research over 15 years.

New Jersey initially followed this requirement but has issued guidance through Technical Bulletins explaining how taxpayers should handle timing differences. For New Jersey purposes, a deduction for research expenditures is allowed as long as the requirements of IRC § 174 and IRC § 41 are met. If there is a timing difference between the federal deduction and the state deduction, taxpayers must account for this on their CBT return in accordance with N.J.S.A. 54:10A-4(k)(11).

Final Thoughts: Strategic Value and Compliance Risk

The Process of Experimentation test is the definitive hurdle for any company seeking to benefit from the New Jersey Research and Development Tax Credit. It transforms the credit from a simple subsidy into a targeted incentive for systematic, high-stakes innovation. For New Jersey businesses, the “re-coupling” with federal law provides a clearer roadmap for compliance but also imports the high documentation standards and audit risks associated with the IRS.

The strategic value of the credit is undeniable, particularly when paired with New Jersey’s unique incentives like the NJEDA tax certificate transfer program. By effectively turning tax credits into non-dilutive capital, New Jersey provides a powerful engine for growth in the life sciences and technology sectors. However, this engine only runs if the company can prove, through contemporaneous records, that its work was not merely routine engineering but a rigorous, iterative process of experimentation designed to eliminate technical uncertainty through the application of hard sciences.

As the New Jersey Division of Taxation continues to modernize its guidance and participate in information exchange programs with the federal government, the margin for error in R&D claims is shrinking. Companies must move beyond general descriptions of “innovation” and “complexity” and instead document the specific hypotheses, the failed iterations, and the refined designs that characterize a true process of experimentation. In doing so, they not only secure their tax benefits but also build a record of technical achievement that is central to the state’s vibrant and growing innovation economy.